Liver fibrosis results from an excessive wound healing response in most chronic liver
diseases, such as hepatitis C. Despite great advances in antiviral therapy in recent years,
progressive liver fibrosis remains a major problem for patients with recurrent hepatitis C after
liver transplantation. Liver biopsy remains a central tool in the management of HCV-positive
liver transplant recipients, but reliable non-invasive methods for the assessment of liver
fibrosis, such as ultrasound elastography, are increasingly being incorporated in the …